GENETIC SOLUTIONS FOR PROFESSIONALSAmplexa Genetics offers cutting-edge testing to help professionals diagnose and select treatment for their patients.
COVID-19 SOLUTIONSWhether it is yourself, your employees or your customers who need to be tested.
Amplexa has the solution.
FERTILITYAmplexa offers: testing of fertilized eggs grown in connection with IVF treatments, testing of future parents for carrier status of rare hereditary diseases, compatibility tests (client-donor) and donor screening tests.
TECHNICAL SOLUTIONSWe have different comprehensive technological solutions that combine science and information technology with our bioinformatics service adaptable to any area.
WE CAN HELP YOU IN YOUR FERTILITY JOURNEYWhen it comes to fertility issues, needs are different and the treatment varies from person to person. Choose the Amplexa test you think corresponds to your situation. You can do this by reading the description below.
I want to have a child with THE HELP OF fertilization treatment.Recommended test: Non invasive PGT-A
We want to be parents but before a pregnancy, we would like to know if our child AT RISK OF inheritING a rare disease.Recommended test: Genes2Life
I want to have a child with the help from a donor. I'm single.
Recommended test: Genes4Life
Amplexa Genetics are experts in providing molecular
genetic analyzes, allowing targeted treatment.
Incorporating epilepsy genetics into clinical practice: a 360°evaluation.We evaluated a new epilepsy genetic diagnostic and counseling service covering a UK population of 3.5 million. We calculated diagnostic yield, estimated clinical impact, and surveyed referring clinicians and families.
Impact on Clinical Decision Making of Next-Generation Sequencing in Pediatric Epilepsy in a Tertiary Epilepsy Referral Center
Next-generation sequencing (NGS) describes new powerful techniques of nucleic acid analysis, which allow not only disease gene identification diagnostics but also applications for transcriptome/methylation analysis and meta-genomics. NGS helps identify many monogenic epilepsy syndromes.
Utility of genetic testing for therapeutic decision-making in adults with epilepsy.Objective: Genetic testing has become a routine part of the diagnostic workup in children with early onset epilepsies. In the present study, we sought to investigate a cohort of adult patients with epilepsy, to determinate the diagnostic yield and explore the gain of personalized treatment approaches in adult patients.